Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Mohammed Al dubayee"'
Autor:
Saif Al Yaarubi, Afaf Alsagheir, Azza Al Shidhani, Somaya Alzelaye, Nadia Alghazir, Imad Brema, Hussain Alsaffar, Mohammed Al Dubayee, Awad Alshahrani, Yasmine Abdelmeguid, Omneya M. Omar, Najya Attia, Elham Al Amiri, Jamal Al Jubeh, Albandari Algethami, Haya Alkhayyat, Azad Haleem, Mouza Al Yahyaei, Ines Khochtali, Saleha Babli, Ahmed Nugud, Nandu Thalange, Sarah Albalushi, Nadia Hergli, Asma Deeb, Majid Alfadhel
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-15 (2024)
Abstract Background Congenital generalized lipodystrophy (CGL) is a rare inherited disease characterized by a near-total absence of adipose tissue and is associated with organ system abnormalities and severe metabolic complications. Here, we have ana
Externí odkaz:
https://doaj.org/article/75ef611592ac46869fbc423ec526ad5f
Autor:
Muhammad Mujammami, Shereen M. Aleidi, Adriana Zardini Buzatto, Awad Alshahrani, Reem H. AlMalki, Hicham Benabdelkamel, Mohammed Al Dubayee, Liang Li, Ahmad Aljada, Anas M. Abdel Rahman
Publikováno v:
Pharmaceuticals, Vol 16, Iss 12, p 1717 (2023)
Metformin is the first-line oral medication for treating type 2 diabetes mellitus (T2DM). In the current study, an untargeted lipidomic analytical approach was used to investigate the alterations in the serum lipidome of a cohort of 89 participants,
Externí odkaz:
https://doaj.org/article/37e64a59ad4a44f1999a44db94f78558
Autor:
Awad Alshahrani, Ahmad Aljada, Afshan Masood, Muhammad Mujammami, Assim A. Alfadda, Mohthash Musambil, Ibrahim O. Alanazi, Mohammed Al Dubayee, Anas M. Abdel Rahman, Hicham Benabdelkamel
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1345 (2023)
Background: Obesity and type 2 diabetes mellitus (T2DM) are characterized by underlying low-grade chronic inflammation. Metformin has been used as the first line of therapy in T2DM as it decreases hepatic glucose production and glucose intestinal abs
Externí odkaz:
https://doaj.org/article/10f1ca8ffe2a4a2d8d6ccbcf2b96eff1
Autor:
Amir Babiker, Wejdan Al Hamdan, Sondos Kinani, Yasser Kazzaz, Abdelhadi Habeb, Talal Al Harbi, Mohammed Al Dubayee, M Al Namshan, Abdul Aleem Attasi
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2021)
The use of antihypertensive medications in patients with pheochromocytomas and paragangliomas (PCC/PG) is usually a challenge. We report a case of familial paraganglioma that was successfully treated by esmolol and other antihypertensive medications
Externí odkaz:
https://doaj.org/article/d6166f75d13f4c50bb0f99c140574f61
Autor:
Hana M. A. Fakhoury, Muhammad Affan Elahi, Saud Al Sarheed, Mohammed Al Dubayee, Awad Alshahrani, Mahmoud Zhra, Arwa Almassri, Ahmad Aljada
Publikováno v:
Medicina, Vol 58, Iss 12, p 1829 (2022)
Background and Objectives: Visceral obesity is associated with chronic low-grade inflammation that predisposes to metabolic syndrome. Indeed, infiltration of adipose tissue with immune–inflammatory cells, including ‘classical’ inflammatory M1 a
Externí odkaz:
https://doaj.org/article/437e75ad9a5b4014b66c47566d405b09
Autor:
Shereen M. Aleidi, Lina A. Dahabiyeh, Xinyun Gu, Mohammed Al Dubayee, Awad Alshahrani, Hicham Benabdelkamel, Muhammad Mujammami, Liang Li, Ahmad Aljada, Anas M. Abdel Rahman
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Metformin is widely used in the treatment of Type 2 Diabetes Mellitus (T2DM). However, it is known to have beneficial effects in many other conditions, including obesity and cancer. In this study, we aimed to investigate the metabolic effect of metfo
Externí odkaz:
https://doaj.org/article/7534c422ee97445b92b4ab5e5ee6c51c
Autor:
Xinyun Gu, Mohammed Al Dubayee, Awad Alshahrani, Afshan Masood, Hicham Benabdelkamel, Mahmoud Zahra, Liang Li, Anas M. Abdel Rahman, Ahmad Aljada
Publikováno v:
Frontiers in Molecular Biosciences, Vol 7 (2020)
Obesity is associated with an increased risk of insulin resistance (IR) and type 2 diabetes mellitus (T2DM) which is a multi-factorial disease associated with a dysregulated metabolism and can be prevented in pre-diabetic individuals with impaired gl
Externí odkaz:
https://doaj.org/article/cbe1407cbb234045b0a3168859a2c7fb
Autor:
Amir Babiker, Amani Idris, Mohammed Aldawsari, Moath Abu Abah, Bothainah Alaqeel, Asim Almotawa, Emad Masuadi, Adnan AlShaikh, Moutasem Azzubi, Mohammed Al Dubayee, Ibrahim Al Alwan, Mohamad Maghnie
Publikováno v:
International Journal of Pediatrics and Adolescent Medicine. 9:196-202
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::716eeef31f2302241ea50deb1c2ae3d3
https://doi.org/10.1016/j.ijpam.2022.11.001
https://doi.org/10.1016/j.ijpam.2022.11.001
Publikováno v:
Advances in Therapy, 39(6), 3042-3057. Springer International Publishing AG
Introduction: Homozygous familial hypercholesterolemia (HoFH) is a rare, life-threatening, inherited condition characterized by extremely elevated levels of low-density lipoprotein cholesterol (LDL-C). Patients are at high risk of atherosclerotic car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b162afc52b7856782edf732119d0da76
https://pure.eur.nl/en/publications/48cfe531-2df7-4f89-bb66-62fb4b9a3d8a
https://pure.eur.nl/en/publications/48cfe531-2df7-4f89-bb66-62fb4b9a3d8a
Publikováno v:
2023 20th Learning and Technology Conference (L&T).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c276f941cf1cc161ebd03c19b479bd5
https://doi.org/10.1109/lt58159.2023.10092297
https://doi.org/10.1109/lt58159.2023.10092297